Starpharma Holdings Limited is biotechnology company involved in the research, development and commercialization of dendrimer-based for pharmaceutical, life sciences and other applications. The Company's lead product in development is VivaGel, a microbicide gel for women, for the prevention and treatment of bacterial vaginosis adn a range of sexually transmitted diseases.

Change in substantial holding

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Starpharma Holdings (SPL AU)

Change in substantial holding

Application for quotation of securities - SPL

Change in Director's Interest Notice - Jeff Davies

Change in substantial holding

Change in Director's Interest Notice - L Cheng

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)